Clinical trials
Care clinical trials
Below are recruiting care clinical trials, each written for real people, not researchers. We’re tracking 3,992 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04604418Recruiting
Tracking outcomes during non-heart procedures in children with heart defects
This study looks at how children with congenital heart disease do during routine non-heart procedures, including medical or minor treatments that are not heart-related. It also measures how much health care they use afterward, which may help improve care planning for families.
Los Angeles, CaliforniaAges Up to 21 years - NCT04474132Recruiting
Testing for current or past Toxoplasmosis infection
This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.
Chicago, IllinoisAges 18–90 - NCT03732131Recruiting
Study of stool bacteria transplant to help people with infections
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
LahtiAges 18–120 - NCT03723928Recruiting
Blood test–guided monitoring for metastatic breast cancer treatment
This study checks whether specific blood “tumor marker” levels can help monitor how hormone receptor–positive, HER2-negative metastatic breast cancer responds to first-line therapy. It uses regular blood tests (and sometimes scans) to see if this marker-based monitoring is useful and reliable.
Anchorage, AlaskaAges 18 years+ - NCT02555735Enrolling by invitation
Study of exceptional responders with solid tumors on chemotherapy
This study looks at people with solid tumor cancer (like many common carcinomas) to understand who responds exceptionally well to chemotherapy. You might be eligible if you are newly diagnosed or already receiving chemotherapy and can follow the study plan.
Los Angeles, CaliforniaAges 18 years+ - NCT07749508Recruiting
Study on gram-negative bacterial infections
This study looks at infections caused by gram-negative bacteria (a type of bacteria that can cause serious illness). It aims to learn more about these infections and how to treat them, which might help improve care for patients with such infections.
Madrid, MadridAges Any age - NCT07748858Recruiting
Heart care support for older African American patients
This study aims to improve care for older African American patients with heart conditions and other health problems. It tests ways to provide more patient-centered support.
Birmingham, AlabamaAges 50–99 - NCT07748949Recruiting
Low-calorie diet and lifestyle help for type 2 diabetes
This study tests whether a low-calorie diet combined with a personalized lifestyle program can help people with type 2 diabetes reach remission, meaning their blood sugar stays normal without needing diabetes medication. It uses a smartphone app to support the program.
BangkokAges 18–70 - NCT05879211Enrolling by invitation
Care learning lab for Duke Health patients
This trial is a “learning laboratory” that studies how best to provide goal-focused care. It may help improve care experiences for Duke Health patients, based on what the study learns.
Durham, North CarolinaAges 18 years+ - NCT06676748RecruitingEarly Phase 1
Benzydamine gargle for sore throat after surgery
This trial tests whether a medicated mouthwash or gargle with benzydamine can help prevent a sore throat after surgery. It's for women having surgery with a type of breathing tube called a laryngeal mask airway.
SingaporeAges 21–80 - NCT06612541Recruiting
Eye imaging test for premature babies at risk of ROP
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
Nashville, TennesseeAges 6 months–8 months - NCT07155174RecruitingPhase 2
Testing new drug combo for first-line extensive small cell lung cancer
This trial tests a new combination treatment (ABBV-706 plus atezolizumab) as a first option for people with extensive stage small cell lung cancer. It compares this new approach to the usual standard treatment, aiming to see if it works better and has fewer side effects.
New Haven, ConnecticutAges 18 years+ - NCT07522866Recruiting
Sleep and Type 1 Diabetes Wellness Study
This study explores how sleep quality affects people with type 1 diabetes. Researchers will work with you to understand your sleep patterns and see if improving sleep helps with diabetes management.
Atlanta, GeorgiaAges 31–75 - NCT07136922RecruitingPhase 1
Testing a new progesterone tablet for luteal phase issues
This trial tests a new progesterone tablet (Callavid) to see if it is safe and easy to use for women with a short or weak luteal phase (the time after ovulation). It may help support early pregnancy and reduce the risk of miscarriage.
CoventryAges 18–45 - NCT07365241RecruitingPhase 3
Study of ABBV-706 vs standard care for advanced small cell lung cancer
This trial tests a new drug called ABBV-706 against standard treatments (topotecan, lurbinectedin, or amrubicin) for people with small cell lung cancer that has come back or stopped responding to previous therapies. The goal is to see if ABBV-706 works better at controlling the cancer.
Birmingham, AlabamaAges 18 years+ - NCT04715191RecruitingPhase 1
CAR T therapy for GPC3-positive pediatric solid tumors
This Phase 1 study tests a customized immune-cell treatment (CAR T cells) made to recognize GPC3, a marker found on some tumors. It’s designed for children and young people whose solid tumors have not been cured by standard treatment and who can safely receive this therapy.
Houston, TexasAges 1–21 - NCT07129226Recruiting
Smartwatch monitoring for leg and pelvis cancer recovery
This study uses a smartwatch to monitor your activity and recovery after treatment for sarcoma or bone cancer in your leg or pelvis. It helps your care team keep track of how you're doing from home.
Cleveland, OhioAges 18 years+ - NCT07750249Enrolling by invitationEarly Phase 1
Short-chain fatty acids for IgA nephropathy
This trial tests whether a daily supplement of short-chain fatty acids (SCFAs) can slow down kidney damage in people with IgA nephropathy. SCFAs are substances made by gut bacteria that may help reduce inflammation and protect the kidneys.
MartinAges 18 years+ - NCT05996328Recruiting
Meal delivery study for older veterans with heart failure
This study tests if providing ready-to-eat meals to older veterans recently hospitalized with heart failure can help them recover and avoid going back to the hospital. It aims to make it easier to follow a heart-healthy diet at home.
Birmingham, AlabamaAges 60 years+ - NCT07284849RecruitingPhase 3
Testing a new drug combo for advanced colorectal cancer
This trial tests whether adding an experimental drug (INCA33890) to standard chemotherapy and bevacizumab helps people with a certain type of advanced colorectal cancer. It is for those whose cancer has spread and has not been treated yet with systemic therapy.
Mobile, AlabamaAges 18 years+ - NCT07114601RecruitingPhase 1
Study of LY4257496 for people with GRPR-positive solid tumors
This trial tests a new drug, LY4257496, in people with certain types of cancer that have a protein called GRPR on their cells. The study aims to see if the drug can help shrink tumors or slow the cancer's growth.
Duarte, CaliforniaAges 18 years+ - NCT07034352Recruiting
Health impact 360: improving heart health in community settings
This trial tests a community program to improve physical, social, and mental health to prevent heart disease. It may be a good fit if you can join group activities and speak English or Spanish.
Detroit, MichiganAges 18 years+ - NCT07068685Enrolling by invitation
Testing a suicide risk tool in primary care
This study is testing a computer program that helps doctors spot people who might be at risk for suicide. If you have a primary care visit at Kaiser Permanente Washington, the program will use your health records to see if you could benefit from extra support.
Seattle, WashingtonAges 18 years+ - NCT07006324Recruiting
Home visits for high-risk postpartum parents in Mississippi Delta
This program offers home visits after childbirth for mothers and parents in the Mississippi Delta who had a high-risk pregnancy. It aims to provide support and care to help you and your baby stay healthy.
Jackson, MississippiAges 18–45
Hear when a new Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for care?
- Yes. Clin2 currently lists 3,992 recruiting care studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a care trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a care trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.